1,368 results on '"Grebely, Jason"'
Search Results
2. Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia
3. Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis
4. Health-related quality of life among people who inject drugs in Australia
5. Understanding hepatitis C virus (HCV) health literacy and educational needs among people in prison to enhance HCV care in prisons
6. The cost-effectiveness of integrating simplified HCV testing into HIV pre-exposure prophylaxis (PrEP) and treatment services among men who have sex with men in Taiwan
7. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study
8. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis
9. Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis
10. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
11. Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
12. Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre‐exposure prophylaxis in Taiwan: a modelling study
13. Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study
14. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial
15. Vaccination coverage among people who inject drugs: A systematic review
16. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions
17. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update
18. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study
19. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review
20. Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: A self-controlled case series in New South Wales, Australia
21. Glecaprevir-pibrentasvir for 4 weeks among people with recent HCV infection: The TARGET3D study
22. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
23. Typology of laws restricting access to methadone treatment in the United States: A latent class analysis
24. A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study
25. Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis
26. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
27. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection
28. ‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue
29. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review
30. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review
31. “You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
32. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study
33. Reinfection incidence and risk among people treated for recent hepatitis C virus infection
34. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
35. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis
36. Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
37. Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection
38. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis
39. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study
40. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study
41. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
42. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
43. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
44. Hepatitis C treatment outcome among people in prison: The SToP‐C study.
45. Point-of-Care Testing for Hepatitis C Infection: A Critical Building Block for the Foundation to Achieve Elimination.
46. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
47. “That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison
48. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative.
49. Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons
50. Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.